SCHEMBL4420375

SCHEMBL4420375

OC[C@H]1OC[C@@H](O)[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16707273 1.00
SCHEMBL608371 1.00
SCHEMBL91129 1.00
SCHEMBL23181030 1.00
SCHEMBL1425304 1.00
SCHEMBL23273618 1.00
SCHEMBL10098563 1.00
SCHEMBL12964371 1.00
SCHEMBL2621328 1.00
SCHEMBL4273375 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017100402-A1 ONE-POT SYNTHESIS OF ANHYDROPENTITOL ESTERS FROM PENTITOLS, CATALYZED BY WATER-TOLERANT LEWIS ACIDS ARCHER DANIELS MIDLAND COMPANY (US) 2017-06-15 WO claimed
WO-2017030685-A1 ONE-POT SYNTHESIS OF ANHYDROPENTITOL MONO- AND DIETHERS ARCHER DANIELS MIDLAND COMPANY (US) 2017-02-23 WO claimed
US-20230241086-A1 ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF CELGENE CORPORATION 2023-08-03 US disclosed
US-11571436-B2 Oral formulations of cytidine analogs and methods of use thereof CELGENE CORPORATION (US) 2023-02-07 US disclosed
US-11020373-B2 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof AMAZENTIS SA (CH) 2021-06-01 US disclosed
US-20170240517-A1 SYNTHESIS OF NON-IONIC AMPHIPHILES FROM 1,4-ANHYDROXYLITOL ARCHER DANIELS MIDLAND CO (US) 2017-08-24 US disclosed
US-7528153-B2 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors GENZYME CORPORATION (US) 2009-05-05 US disclosed
US-20090036553-A1 DENDRITIC ENCAPSULATION OF ACTIVE AGENTS SHIRE LLC (US) 2009-02-05 US disclosed
US-20070066581-A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors GENZYME CORPORATION 2007-03-22 US disclosed
EP-1680403-A1 DEOXYNOJIRIMYCIN ANALOGUES AND THEIR USES AS GLUCOSYLCERAMIDASE INHIBITORS MacroZyme B.V. (NL) 2006-07-19 EP disclosed
WO-2005040118-A1 DEOXYNOJIRIMYCIN ANALOGUES AND THEIR USES AS GLUCOSYLCERAMIDASE INHIBITORS MACROZYME B.V. (NL) 2005-05-06 WO disclosed
EP-1528056-A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors Academisch Ziekenhuis bij de Universiteit van Amsterdam (NL) 2005-05-04 EP disclosed